reducing clinical inertia in type 2 diabetes: a case for early combination therapy
Published 6 years ago • 582 plays • Length 39:05Download video MP4
Download video MP3
Similar videos
-
37:35
fixed ratio glp-1 ra and basal insulin combinations: role in treatment intensification
-
5:23
overcoming clinical inertia in type 2 diabetes
-
54:25
preventing clinical inertia in diabetes
-
10:24
therapeutic inertia: what you need to know
-
5:47
overcoming clinical inertia in patients with t2dm
-
58:46
overcoming therapeutic inertia in type 2 diabetes—benefiting patients, clinicians and health systems
-
1:14
case scenario 2 - combination basal insulin glp-1ra therapy
-
50:35
tackling therapeutic inertia: american diabetes association standard of care updates
-
3:27
clinical inertia: a barrier to treating diabetes
-
27:54
strategies to overcome therapeutic inertia
-
40:07
incorporating long-acting insulin therapy into the physiologic approach to diabetes management
-
47:29
insulin dosing & therapeutic inertia in the time of covid-19
-
25:22
diabetes management: overcoming barriers to the initiation of long-acting insulin therapy
-
37:06
internal medicine grand rounds: new goals and therapeutic options for type 2 diabetes
-
39:11
incretin-related therapies: glycemic control and beyond
-
0:14
magic formula to reverse insulin resistance no one is telling you
-
49:54
management of hyperglycemia in type 2 diabetes - ada/easd part- 4
-
27:47
how long will it take to address clinical inertia in t2dm?
-
0:54
combination therapy for diabetes